Trial Profile
Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Rizatriptan (Primary) ; Caffeine
- Indications Migraine
- Focus Therapeutic Use
- 22 Apr 2009 Results presented at AAN 2009.
- 29 Jan 2009 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
- 29 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.